- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT02550990
Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition in Stroke Patients With Cognitive Decline
Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition, Physiological Markers, Daily Function and Quality of Life in Stroke Patients With Cognitive Decline
Tutkimuksen yleiskatsaus
Tila
Opintotyyppi
Ilmoittautuminen (Odotettu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Chiayi City, Taiwan, 613
- Rekrytointi
- Chiayi Chang Gung Memorial Hospital
-
Ottaa yhteyttä:
- Shi-Zhe Lin, MS
- Puhelinnumero: 2688 +886-5-3621000
- Sähköposti: apirlline@cgmh.org.tw
-
Kaohsiung City, Taiwan, 83301
- Rekrytointi
- Kaohsiung Chang Gung Memorial Hospital
-
Ottaa yhteyttä:
- Ku-Chou Chang, MD
- Puhelinnumero: 2285 +886-7317123
- Sähköposti: kcchang@cgmh.org.tw
-
Keelung City, Taiwan, 204
- Rekrytointi
- Keeling Chang Gung Memorial Hospital
-
Ottaa yhteyttä:
- Chia-Ling Chen, PhD
- Puhelinnumero: 8147 +886-3-3281200
- Sähköposti: ccl1374@adm.cgmh.com.tw
-
Taipei City, Taiwan, 105
- Rekrytointi
- Taipei Chang Gung Memorial Hospital
-
Ottaa yhteyttä:
- Chia-Ling Chen, PhD
- Puhelinnumero: 8147 +886-3-3281200
- Sähköposti: ccl1374@adm.cgmh.com.tw
-
Taoyuan City, Taiwan, 333
- Rekrytointi
- Taoyuan Chang Gung Memorial Hospital
-
Ottaa yhteyttä:
- Chia-Ling Chen, PhD
- Puhelinnumero: 8147 +886-3-3281200
- Sähköposti: ccl1374@adm.cgmh.com.tw
-
-
Taoyuan
-
Kwei-Shan, Taoyuan, Taiwan, 333
- Rekrytointi
- Chang Gung Memorial Hospital
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Ischemic or hemorrhagic stroke occurring at least 6 months prior to enrollment
- Age range from 20 to 90 years
- MMSE score ≥ 19
- MoCA<26
- Self- or informant-reported memory or cognitive complaints or CDR scale ≤ 0.5
- Able to follow the study instruction
- Adequate cardiopulmonary function to perform aerobic exercise
- Able to walk with or without assistive devices
Exclusion Criteria:
- Unstable medical history (e.g., recent myocardial infarction) that might limit participation
- Concomitant with other neurological disorders (e.g., Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis)
- Current participation in another interventional trial
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Active Comparator: Cognitive training group
One 60-min session of cognitive training.
Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.).
A saliva sample (2 mL) will only be collected once from each subject.
A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
|
|
|
Active Comparator: Aerobic exercise training group
One 60-min session of aerobic exercise training.
Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.).
A saliva sample (2 mL) will only be collected once from each subject.
A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
|
|
|
Kokeellinen: Sequential training group
One 30-min session of aerobic exercise training + one 30-min session of cognitive training. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change scores of Montreal Cognitive Assessment (MoCA)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Wechsler Memory Scale - Third Edition (WMS-III)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Wechsler Adult Intelligence Scale - Third Edition (WAIS-III)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Useful Field of View (UFOV)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Stroop Color-Word test
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Dual-task test
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
The dual-task tests will be assessed to determine the ability for an individual to perform 2 tasks simultaneously.
The investigators will assess the dual-task performance during walking and performing box and block test.
The results of the dual-task tests will provide information regarding to whether the 2 tasks compete for the same class of neural resources or one of the tasks can be carried out automatically.
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Muuta antioksidanttimarkkerin arvoja
Aikaikkuna: Lähtötilanne, jälkitesti (oletettu keskiarvo 3 kuukautta)
|
Antioksidatiivisia markkereita käytetään heijastamaan muutoksia oksidatiivisessa stressissä.
Erityisesti aiomme analysoida kokonaisantioksidanttikapasiteettia (TAC).
|
Lähtötilanne, jälkitesti (oletettu keskiarvo 3 kuukautta)
|
|
Muuta plasman lipiditasoja
Aikaikkuna: Lähtötilanne, jälkitesti (oletettu keskiarvo 3 kuukautta)
|
Kolesterolisuhde (kokonaiskolesteroli jaettuna korkeatiheyksisellä lipidillä) arvioidaan heijastamaan veren lipiditasoa.
|
Lähtötilanne, jälkitesti (oletettu keskiarvo 3 kuukautta)
|
|
Change scores of serum BDNF level
Aikaikkuna: Baseline, posttest (an expected average of 3 months)
|
Baseline, posttest (an expected average of 3 months)
|
|
|
Change scores of Glucose indicator
Aikaikkuna: Baseline, posttest (an expected average of 3 months)
|
HbA1C level will be tested to investigate the relationships between blood glucose level and aerobic exercise.
|
Baseline, posttest (an expected average of 3 months)
|
|
Change scores of Functional Independence Measure (FIM)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Lawton Instrumental Activities of Daily Living Scale (Lawton IADL)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Stroke Impact Scale (SIS)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Caregiver Burden (CB) scale
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of EuroQol (EQ)-5D questionnaire
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Timed up and go test (TUG)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Six-minute walk test (6MWT)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Mobility level
Aikaikkuna: Baseline, posttest (an expected average of 3 months)
|
Baseline, posttest (an expected average of 3 months)
|
|
|
Change scores of International Physical Activity Questionnaires (IPAQ)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Fugl-Meyer Assessment (FMA)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Rivermead Mobility Index (RMI)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of muscle strength
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
We will evaluate isometric knee flexors and extensors muscle strength using handheld dynamometer.
Also, we will use hand dynamometer to measure grip strength of the affected and less affected hand while the participant is seated, with the elbow at 90-degree flexion.
We will record the mean value of 3 attempts.
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
Change scores of Community Integration Questionnaire (CIQ)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Geriatric Depression Scale (GDS)
Aikaikkuna: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Genotyping of the BDNF val66met polymorphism
Aikaikkuna: Between baseline and posttest (an expected average of 3 months)
|
Between baseline and posttest (an expected average of 3 months)
|
Yhteistyökumppanit ja tutkijat
Sponsori
Julkaisuja ja hyödyllisiä linkkejä
Yleiset julkaisut
- Gibson E, Koh CL, Eames S, Bennett S, Scott AM, Hoffmann TC. Occupational therapy for cognitive impairment in stroke patients. Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD006430. doi: 10.1002/14651858.CD006430.pub3.
- Yeh TT, Wu CY, Hsieh YW, Chang KC, Lee LC, Hung JW, Lin KC, Teng CH, Liao YH. Synergistic effects of aerobic exercise and cognitive training on cognition, physiological markers, daily function, and quality of life in stroke survivors with cognitive decline: study protocol for a randomized controlled trial. Trials. 2017 Aug 31;18(1):405. doi: 10.1186/s13063-017-2153-7.
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus
Ensisijainen valmistuminen (Odotettu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Arvio)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- 104-4892A3
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .